CD79A and rheumatoid arthritis: In studies of pre-clinical RA, serum levels of anti-MAA IgG and IgA antibodies are increased approximately 3 years before RA disease onset and are higher in patients with established disease compared to healthy controls and patients with alternative rheumatologic diagnoses (30, 31, 33, 35, 39).